BeiGene Ltd. (49B) — Capital Reinvestment Ratio

Latest as of March 2025: 2.64x

BeiGene Ltd. (49B) has a Capital Reinvestment Ratio of 2.64x as of March 2025, meaning it reinvests 3% of its operating cash flow (€44.08 Million) in capital expenditures (€116.41 Million). Check tangible net worth ratio of BeiGene Ltd. to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

2.64x

Capex / Operating Cash Flow

Operating Cash Flow

€44.08 Million

EUR

Capital Expenditures

€116.41 Million

EUR

Data as of

Mar 2025

Most recent filing

BeiGene Ltd. Capital Reinvestment Ratio (2017–2017)

This chart tracks BeiGene Ltd.'s Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see BeiGene Ltd. (49B) cash flow conversion.

Annual Capital Reinvestment Ratio for BeiGene Ltd. (2017–2017)

Year-by-year Capital Reinvestment Ratio for BeiGene Ltd. from 2017 to 2017. See 49B FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change
2017	3.64x	€12.75 Million	€46.37 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow